Barings LLC Lowers Stake in Masimo Corporation (NASDAQ:MASI)
Barings LLC cut its position in shares of Masimo Corporation (NASDAQ:MASI) by 15.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,400 shares of the medical equipment provider’s stock after selling 1,000 shares during the period. Barings LLC’s holdings in Masimo Corporation were worth $504,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of MASI. JPMorgan Chase & Co. boosted its stake in shares of Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock worth $42,466,000 after buying an additional 45,833 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in Masimo Corporation by 6.2% in the fourth quarter. Thrivent Financial for Lutherans now owns 23,760 shares of the medical equipment provider’s stock valued at $1,601,000 after buying an additional 1,390 shares during the period. Geode Capital Management LLC boosted its stake in Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock valued at $60,175,000 after buying an additional 173,931 shares during the period. Swiss National Bank boosted its stake in Masimo Corporation by 0.9% in the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock valued at $7,256,000 after buying an additional 700 shares during the period. Finally, Norges Bank bought a new stake in Masimo Corporation during the fourth quarter valued at approximately $26,532,000. Institutional investors own 84.61% of the company’s stock.
Shares of Masimo Corporation (MASI) traded down 1.58% during mid-day trading on Friday, reaching $85.29. The company’s stock had a trading volume of 1,120,107 shares. Masimo Corporation has a 52-week low of $52.07 and a 52-week high of $104.71. The firm’s 50 day moving average is $93.60 and its 200-day moving average is $89.40. The company has a market capitalization of $4.43 billion, a PE ratio of 13.98 and a beta of 0.80.
Masimo Corporation (NASDAQ:MASI) last released its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The firm had revenue of $192.90 million during the quarter, compared to analysts’ expectations of $189.03 million. Masimo Corporation had a return on equity of 25.75% and a net margin of 45.90%. The company’s revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.57 EPS. Analysts forecast that Masimo Corporation will post $2.78 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/04/masimo-corporation-nasdaqmasi-shares-sold-by-barings-llc-updated-updated-updated.html.
MASI has been the subject of several analyst reports. Stifel Nicolaus initiated coverage on Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price target for the company. Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. BidaskClub upgraded Masimo Corporation from a “hold” rating to a “buy” rating in a research report on Wednesday, July 12th. Zacks Investment Research upgraded Masimo Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Finally, Wedbush reiterated an “outperform” rating and issued a $112.00 price objective on shares of Masimo Corporation in a research report on Monday, May 22nd. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Masimo Corporation currently has an average rating of “Hold” and an average target price of $87.50.
In other news, insider Rick Fishel sold 15,000 shares of the firm’s stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $94.85, for a total value of $1,422,750.00. Following the completion of the transaction, the insider now owns 35,022 shares in the company, valued at approximately $3,321,836.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jon Coleman sold 25,000 shares of the firm’s stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $97.50, for a total value of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares of the company’s stock, valued at approximately $3,139,597.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 115,000 shares of company stock valued at $10,773,180. Corporate insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.